Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis.

@article{Rostholder2012OutcomesAE,
  title={Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis.},
  author={E Rostholder and Aadil Ahmed and Adam S. Cheifetz and Alan C. Moss},
  journal={Alimentary pharmacology & therapeutics},
  year={2012},
  volume={35 5},
  pages={562-7}
}
BACKGROUND Infliximab (IFX) therapy escalation during maintenance treatment occurs frequently in clinical practice in patients with ulcerative colitis (UC). Outcomes for these patients have not been described. AIM To describe the prevalence of, and outcomes after, IFX escalation during maintenance therapy in patients with moderate-severe UC. METHODS… CONTINUE READING